RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ADAP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Adaptimmune Therapeutics plc stock price on Wednesday moving between $1.47 and $1.63
(Updated on Mar 27, 2024)

Buy or Hold candidate since Mar 22, 2024 Gain 9.72% PDF

The Adaptimmune Therapeutics plc stock price gained 3.95% on the last trading day (Wednesday, 27th Mar 2024), rising from $1.52 to $1.58. During the last trading day the stock fluctuated 10.54% from a day low at $1.47 to a day high of $1.63. The price has risen in 5 of the last 10 days but is still down by -0.63% for this period. Volume fell on the last day by -14 thousand shares and in total, 1 million shares were bought and sold for approximately $1.86 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 106.89% during the next 3 months and, with a 90% probability hold a price between $2.91 and $4.07 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ADAP Signals & Forecast

The Adaptimmune Therapeutics plc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $1.44 and $1.45. A breakdown below any of these levels will issue sell signals. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, March 08, 2024, and so far it has fallen -9.71%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Adaptimmune Therapeutics plc stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.50 and $1.44. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Adaptimmune Therapeutics plc finds support just below today's level at $1.50. If this is broken, then the next support from accumulated volume will be at $1.44 and $1.33.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.155 between high and low, or 10.54%. For the last week, the stock has had daily average volatility of 10.90%.

Our recommended stop-loss: $1.50 (-5.04%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 13 days ago.)

Trading Expectations (ADAP) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Adaptimmune Therapeutics plc to open at $1.56, and during the day (based on 14 day Average True Range), to move between $1.41 and $1.75, which gives a possible trading interval of +/-$0.167 (+/-10.60%) up or down from last closing price. If Adaptimmune Therapeutics plc takes out the full calculated possible swing range there will be an estimated 21.20% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.50 (5.06%) than the resistance at $1.71 (8.23%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Adaptimmune Therapeutics plc stock A Buy?

Adaptimmune Therapeutics plc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.526 Hold/Accumulate Downgraded

Predicted Opening Price for Adaptimmune Therapeutics plc of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$1.56 ( 1.37%) $1.58

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ADAP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.71 8.44 %
R2 1.65 4.69 %
R1 1.62 2.38 %
Current price: 1.58
Support S1 1.50 -5.12 %
S2 1.46 -7.43 %
S3 1.40 -11.18 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.75 10.76 %
R2 1.74 10.13 %
R1 1.71 8.23 %
Current price 1.58
Support S1 1.50 -5.06%
S2 1.44 -8.86%
S3 1.33 -15.82%

FAQ

What is the symbol for Adaptimmune Therapeutics plc Stock and on which exchange is it traded?
The symbol for Adaptimmune Therapeutics plc is ADAP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Adaptimmune Therapeutics plc Stock?
Adaptimmune Therapeutics plc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Adaptimmune Therapeutics plc Stock?
Adaptimmune Therapeutics plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Adaptimmune Therapeutics plc Stock.

What's the current price of Adaptimmune Therapeutics plc Stock?
As of the end of day on the 2024-03-27, the price of an Adaptimmune Therapeutics plc (ADAP) share was $1.58.

What is the 52-week high and low for Adaptimmune Therapeutics plc Stock?
The 52-week high for Adaptimmune Therapeutics plc Stock is $2.05 and the 52-week low is $0.420.

What is the market capitalization of Adaptimmune Therapeutics plc Stock?
As of the 2024-03-27, the market capitalization of Adaptimmune Therapeutics plc is 345.295M.

When is the next earnings date for Adaptimmune Therapeutics plc?
The upcoming earnings date for Adaptimmune Therapeutics plc is May 10, 2024.
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT